Clinical Trial Update: Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use [Phase 4]

View source ↗

Summary

Phase 4 study assessing as-needed Selincro (nalmefene) for alcohol dependence in patients with impaired liver function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Selincro (nalmefene hydrochloride dihydrate)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED